subscribeSubscribe
Kazia Announces The Release Of Pnoc022 Clinical Study Abstract

Kazia Announces The Release Of Pnoc022 Clinical Study Abstract
PR NEWSWIRE
15 Nov 2023
Share Share
Kazia Announces Publication In Cancer Therapeutics Highlighting Paxalisib Data

Kazia Announces Publication In Cancer Therapeutics Highlighting Paxalisib Data
PR NEWSWIRE
10 Nov 2023
Share Share
Kazia Provides Preliminary Update From Ongoing Phase 2 Study Of Paxalisib

Kazia Provides Preliminary Update From Ongoing Phase 2 Study Of Paxalisib
PR NEWSWIRE
01 Nov 2023
Share Share
PNOC Clinical Study Of Kazia`s Paxalisib In Childhood Brain Cancer Expands

PNOC Clinical Study Of Kazia`s Paxalisib In Childhood Brain Cancer Expands
BENZINGA
06 Oct 2022
Share Share
Kazia Tx Reports Promising Interim Data From Combination Study Of Paxalisib

Kazia Tx Reports Promising Interim Data From Combination Study Of Paxalisib
PRNEWSWIRE
05 Aug 2022
Share Share
Kazia dropped from global umbrella trial to treat brain cancer

Kazia dropped from global umbrella trial to treat brain cancer
Max Bayer FIERCEBIOTECH
01 Aug 2022
Share Share
FDA Awards RPDD To Paxalisib For At/Rt

FDA Awards RPDD To Paxalisib For At/Rt
PRNEWSWIRE
06 Jul 2022
Share Share
FDA Awards ODD To Paxalisib For At/Rt, A Rare Form Of Childhood Brain Cancer

FDA Awards ODD To Paxalisib For At/Rt, A Rare Form Of Childhood Brain Cancer
PRNEWSWIRE
17 Jun 2022
Share Share
Kazia reports positive results from Phase II trial of glioblastoma therapy

Kazia reports positive results from Phase II trial of glioblastoma therapy
CLINICALTRIALSARENA
06 Dec 2021
Share Share
Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib

Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib
PRNEWSWIRE
04 Dec 2021
Share Share